Cargando…
Clinical Intervention Increases Rational Use of Proton Pump Inhibitors in the General Surgery Department
This study aimed to evaluate the role of the clinical pharmacist in the rational use of proton pump inhibitors (PPIs) in a general surgery department. All enrolled patients had attended the general surgery department of a tertiary hospital. This single-center prospective study compared differences i...
Autores principales: | Chen, Qiying, Wang, Qiaohong, Zhang, Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083545/ https://www.ncbi.nlm.nih.gov/pubmed/35548351 http://dx.doi.org/10.3389/fphar.2022.864081 |
Ejemplares similares
-
Proton Pump Inhibitors in IPF: A Call for Clinical Trials
por: Ghebre, Yohannes T.
Publicado: (2018) -
Proton-pump inhibitor use amongst patients with severe hypomagnesemia
por: Seah, Sherry, et al.
Publicado: (2023) -
Proton Pump Inhibitors and Cancer: Current State of Play
por: Bridoux, Marie, et al.
Publicado: (2022) -
The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital
por: Xin, Chuanwei, et al.
Publicado: (2017) -
Using proton pump inhibitors increases the risk of hepato-biliary-pancreatic cancer. A systematic review and meta-analysis
por: Zhou, Wence, et al.
Publicado: (2022)